Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Maria Chiara TISI"'
Autor:
Maria Chiara Tisi, Michelina Dargenio, for Sorveglianza Epidemiologica Infezioni nelle Emopatie, Federica Lessi, Francesca Farina, Livio Pagano, Andrea Visentin, Angelica Spolzino, Luca Laurenti, Davide Facchinelli, M. Picardi, Gianpaolo Nadali, Chiara Cattaneo, Fabio Trastulli, Luisa Verga, Francesco Marchesi, Anna Candoni, Alessandro Busca, Lucia Prezioso, Gessica Marchesini, Rosa Fanci
Publikováno v:
British Journal of Haematology
Summary We describe the opportunistic infections occurring in 362 patients with lymphoproliferative disorders treated with ibrutinib and idelalisib in clinical practice. Overall, 108 of 362 patients (29·8%) developed infections, for a total of 152 e
Autor:
Francesco Merli, Carlo Visco, Annarita Conconi, Daniele Vallisa, Elettra Ortu La Barbera, Sara Galimberti, Roberto Mina, Marianna Sassone, Anna Guidetti, Adriano Venditti, Alessandro Corso, Francesco Marchesi, Pellegrino Musto, Agostino Tafuri, Valentina Bonuomo, Filippo Gherlinzoni, Francesco Lanza, Monia Marchetti, Safaa M. Ramadan, Marco Salvini, Massimo Massaia, Elisa Coviello, Alessandro Busca, Luigi Petrucci, Daniele Armiento, Mauro Turrini, Alessandra Romano, Chiara Cattaneo, Francesco Passamonti, Matteo G. Della Porta, Anna Candoni, Luigi Rigacci, Luca Arcaini, Livio Trentin, Valeria Cardinali, Maria Chiara Tisi, Carmine Selleri, Carlo Gambacorti-Passerini, Andrés J.M. Ferreri, Patrizia Tosi, Riccardo Bruna, Mauro Krampera, Antonio Cuneo, Nicola Stefano Fracchiolla, Daniela Cilloni, Lorenza Bertù, Paolo Corradini, Annamaria Scattolin, Roberto Cairoli, Giuseppe Visani, Domenico Penna, Marco Ladetto, Antonello Pinto, Michele Cavo, Monica Bocchia, Sofia Pilerci, Luigi Marcheselli
Publikováno v:
Blood Advances
Lymphoma represents a heterogeneous hematological malignancy (HM), which is characterized by severe immunosuppression. Patients diagnosed of coronavirus disease 2019 (COVID-19) during the course of HM have been described to have poor outcome, with on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c511abaff8f6767b1c8847f0db05744
http://hdl.handle.net/11568/1132840
http://hdl.handle.net/11568/1132840
Autor:
Luisa Verga, Chiara Cattaneo, Monica Piedimonte, Rosa Fanci, Gianpaolo Nadali, Mariagrazia Garzia, Enrico Orciulo, Barbara Veggia, Angelica Spolzino, Nicola Toschi, Federica Lessi, Daniele Zama, Nicola Stefano Fracchiolla, Leonardo Potenza, Maria Chiara Tisi, Alessandro Busca, Mario Delia, Maria Ilaria Del Principe, Lucia Prezioso, Carlo Castagnola, Nunzia Decembrino, Valentina Mancini, Allegra Conti, Giulia Dragonetti, Francesco Marchesi, Sara Manetta, Anna Candoni, Michelina Dargenio, Lorella Melillo, Livio Pagano, Marco Picardi, Stelvio Ballanti, Domenico Russo
Background: In patients with relapsed/refractory acute myeloid leukaemia (R/R AML) who received salvage chemotherapy, limited and not updated studies explored the incidence of invasive aspergillosis (IA) and the role of antifungal prophylaxis (AP). T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6fad6d192811f13a978d222525f2f8d
https://hdl.handle.net/11380/1281417
https://hdl.handle.net/11380/1281417
Autor:
Jacopo Olivieri, Davide Facchinelli, Roberto Sartori, Rossella Paolini, Marco Basso, Francesco Piazza, Carlo Visco, Greta Scapinello, Elisa Lucchini, Gianmarco Guandalini, Giulia Bega, Isacco Ferrarini, Marcello Riva, Silvia Finotto, Laura Ballotta, Maria Chiara Tisi
Publikováno v:
Cancers
Cancers, Vol 13, Iss 6089, p 6089 (2021)
Cancers; Volume 13; Issue 23; Pages: 6089
Cancers, Vol 13, Iss 6089, p 6089 (2021)
Cancers; Volume 13; Issue 23; Pages: 6089
Simple Summary Both BR, and R-BAC are suitable induction therapies in elderly patients with mantle cell lymphoma (MCL). However, the two regimens have not been compared before. We retrospectively analysed the outcome and the safety features of elderl
Autor:
Attilio Olivieri, Chiara Rusconi, Ombretta Annibali, Maria Giuseppina Cabras, Maria Chiara Tisi, Monica Balzarotti, Giacomo Loseto, Alice Di Rocco, Luca Nassi, Annalisa Chiappella, Andrés José Maria Ferreri, Massimo Gentile, Guido Gini, Annalisa Arcari
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
Central nervous system (CNS) involvement is a rare but almost fatal complication of diffuse large B-cell lymphoma (DLBCL). There is no consensus on the optimal CNS risk model and prophylaxis treatment. We conducted in all FIL centers a web-based surv
Autor:
Anna Guidetti, Maria Chiara Tisi, Rosalba Miceli, Matteo Carrabba, P. L. Zinzani, Patrizia Chiusolo, A. Di Rocco, Massimo Martino, Beatrice Casadei, Anna Maria Barbui, Paolo Corradini, Anna Dodero, C. Carniti, Annalisa Chiappella, Armando Santoro, Stefania Bramanti
Publikováno v:
Hematological Oncology. 39
Autor:
M. Ponzoni, Piera Angelillo, M. M.B Salvador Chalup, C. Muzi, Maria Dimou, Potito Rosario Scalzulli, F. L. Nogueira, Emilio Iannitto, D. Onofrillo, Anna Ferreri, Marco Foppoli, Monica Tani, F. Cocito, P. Ramakrishnan, Alessia Castellino, T. Calimeri, Vittoria Tarantino, P. L. Zinzani, Kate Cwynarski, Alessandra Tucci, Felicetto Ferrara, T.P. Vassilakopoulos, G. Cabras, Andrew Davies, Luigi Petrucci, Andrea Ferrario, Sotirios G. Papageorgiou, Maria Chiara Tisi, Luca Arcaini
Publikováno v:
Hematological Oncology. 39
Autor:
B. Famengo, Rossella Paolini, Cristina Tecchio, Erika Ravelli, Emanuele S.G. d'Amore, Roberto Sartori, Carlo Visco, Omar Perbellini, Marco Ruggeri, Francesco Piazza, Eros Di Bona, Maria Chiara Tisi, Giuseppe Carli
Publikováno v:
American Journal of Hematology. 93:E386-E389
Autor:
Guido Gini, Piero Maria Stefani, Luca Nassi, Tommasina Perrone, Simon Rule, Monica Balzarotti, Cristina Tecchio, Valentina Bozzoli, Antonello Sica, Luca Arcaini, Alessandro Re, Carlo Visco, Annalisa Chiappella, Maria Christina Cox, Simone Ferrero, Roberta Sciarra, Maria Chiara Tisi, Mauro Krampera, Chiara Rusconi, Andrea Evangelista, Vittorio Ruggero Zilioli, Maria Isabel Alvarez De Celis, Alice Di Rocco, Elsa Pennese, Ana Marin-Niebla, Rory McCulloch, Alberto Fabbri, Umberto Vitolo, Lucia Morello, Francesca Maria Quaglia, Stefan Hohaus, Valentina Polli, Luca Petrucci
Patients with mantle cell lymphoma (MCL) that fail induction treatment represent a difficult-to-treat population, where no standard therapy exists. We evaluated outcomes in patients with first relapsed-refractory (r/r) MCL after upfront high dose cyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cb9271c7ec247f0468782f0ca4b6036
http://hdl.handle.net/2318/1791410
http://hdl.handle.net/2318/1791410
Autor:
Cristina Tecchio, Lucia Morello, Carlo Visco, Chiara De Philippis, Roberta Sciarra, Maria Chiara Tisi, Maria Isabel Alvarez De Celis, Luca Nassi, Irene Dogliotti, Alice Di Rocco, Luigi Marcheselli, Nicola Bianchetti, Annalisa Arcari, Vittorio Ruggero Zilioli, Michele Merli, Anna Lia Molinari, Guido Gini, Tommasina Perrone, Annalisa Chiappella, Valentina Bozzoli, Stefano Volpetti, Francesca Maria Quaglia, Stefan Hohaus, Matteo Pelosini, Alberto Fabbri, Daniele Vallisa
The role of allogeneic stem cell transplantation (allo-SCT) in mantle cell lymphoma (MCL) is uncertain, even more in the era of bruton's tyrosine kinase inhibitors (BTKi) and chimeric antigen receptor T-cells. We retrospectively analyzed 55 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67f0e3d30712ac80055a5c9803e8e000
http://hdl.handle.net/11562/1064985
http://hdl.handle.net/11562/1064985